Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > From Sedar

<< Previous

Bullboard Posts

Next >>

Comment by NeilPaert74on Oct 07, 2020 6:19pm

120 Views

Post# 31684207

RE:RE:RE:RE:RE:From Sedar

enriquesuave wrote: Sorry you are showing $7 Million and I think there's another batch of 50's for total of maybe 8-9$. Million, not 10

Plenty of monies $$ to gear up production of 1433 and DFOCs, run a nationwide Keytruda sucks! commercial campaign in 2022. ;-)

Assuning they keep all of the studies to cheap-O-canada and get the FDA BTD and accelerated approval. After a 1 yr CR very high %.

<< Previous

Bullboard Posts

Next >>

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire